Key result
Roux-en-Y gastric bypass improves glucose tolerance and insulin sensitivity versus sham surgery in obese rats.
Why the study?
Does Roux-en-Y gastric bypass improve glucose tolerance and insulin sensitivity in genetically obese Zucker rats?
Does Roux-en-Y gastric bypass improve glucose tolerance and insulin sensitivity in genetically obese Zucker rats?
p-value: p=<0.05
In an obese Zucker rat model, RYGB improves glucose homeostasis and insulin sensitivity through increased postprandial incretins and decreased subcutaneous fat, independent of food restriction.
RYGB metabolic effects in obese rats extend preclinical models; leaves open translation to human bariatric outcomes.
In Brief Objective: Obesity-related diabetes is caused by insulin resistance and β-cell dysfunction. The current study examines changes in food intake, weight loss, body fat depots, oxygen consumption, insulin sensitivity, and incretin levels as potential mechanisms for improved glucose tolerance after Roux-en-Y gastric bypass (RYGB). Methods: Three groups of genetically obese Zucker rats were studied: RYGB, sham surgery pair-fed (PF), and sham surgery ad libitum (AL) fed rats. Changes in body weight, visceral and subcutaneous fat depots, oral glucose tolerance, insulin sensitivity, and the plasma concentrations of insulin, glucagon, glucagon-like peptide-1 (GLP-1), glucose-dependent insulinotropic peptide, and peptide YY (PYY) were measured. Results: Body weight and subcutaneous fat were decreased after RYGB, compared with the PF and AL groups. The reduction in visceral fat after RYGB appeared largely because of food restriction. Glucose tolerance and insulin sensitivity were significantly improved in only the RYGB group (P < 0.05 vs. AL, PF). Euglycemic, hyperinsulinemic clamp studies indicated RYGB improved the ability of insulin to stimulate peripheral (eg, skeletal muscle) glucose uptake. Fasting total GLP-1, glucose-dependent insulinotropic peptide, and PYY levels were similar between the groups, whereas postprandial plasma levels of intact GLP-1 (7-36) amide, total GLP-1, and PYY were increased in the RYGB group compared with PF and AL controls. Conclusions: Glucose homeostasis after RYGB is associated with decreased subcutaneous fat, increased postprandial PYY, GLP-1, and insulin, as well as improved insulin sensitivity/action. Changes in food intake and visceral fat do not seem to explain improvements in insulin action after RYGB in the Zucker rat model. After Roux-en-Y gastric bypass (RYGB), diabetic patients demonstrate improvements in glucose control before significant weight loss. The current study examines potential mechanisms for post-RYGB glucose homeostasis in the obese Zucker rat. The results suggest increased postprandial incretin levels and improvements in insulin sensitivity/action contribute post-RYGB glucose homeostasis.
No takes yet. Share an insight, caveat, or question.
Meirelles et al. (2009) studied Obesity-related diabetes and insulin resistance. Roux-en-Y gastric bypass (RYGB) vs. Sham surgery pair-fed (PF) and sham surgery ad libitum (AL) fed rats was evaluated on Glucose tolerance and insulin sensitivity (p=<0.05). Roux-en-Y gastric bypass significantly improved glucose tolerance and insulin sensitivity in obese Zucker rats compared to sham surgery controls (P < 0.05).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: